Fresenius Kabi
Mukul Agrawal is a highly experienced professional currently serving as the Global Senior Director and Head of Strategy & Business Transformation for Nutrition at Fresenius Kabi since November 2024. Previously, Mukul held the position of Project Leader at Boston Consulting Group from January 2024 to October 2024. At BASF, from October 2014 to December 2023, Mukul led significant initiatives including the Global Plastic Circularity Roadmap and served as Director of Product Management for Performance Materials in North America, managing a team of over 25 and overseeing a business segment with an annual turnover exceeding €1 billion. Mukul's experience also includes roles at Siemens Management Consulting, Henkel, Unilever, and Roche, complemented by a strong academic background with a Master's degree in Strategy & International Management from the University of St.Gallen.
This person is not in any teams
This person is not in any offices
Fresenius Kabi
16 followers
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients. Fresenius Kabi’s product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the devices for administering these products. In the field of biosimilars, Fresenius Kabi focuses on autoimmune diseases and oncology. In 2019, the first biosimilar product by Fresenius Kabi was launched. Within transfusion medicine and cell therapies, Fresenius Kabi offers products for collection of blood components and extracorporeal therapies.